Notice of Saniona AB annual shareholders’ meeting
PRESS RELEASE April 23, 2021 The English text is an unofficial translation. In case of any discrepancies between the Swedish...
Month: April 2021
Nicox’s NCX 4251 Mississippi Phase 2b Blepharitis Trial Reaches 50% Enrollment
Press ReleaseNicox’s NCX 4251 Mississippi Phase 2b Blepharitis Trial Reaches 50% Enrollment102 patients randomized as of April 22, 2021, out...
Vistin Pharma ASA: First quarter 2021 financial results
Oslo, Norway, 23rd of April 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the...
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Application is based on Phase 2b/3 SELECTION study data with patients with moderately to severely active ulcerative colitis Mechelen, Belgium;...
Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy
About 90,000 women globally die from endometrial cancer each year1VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in...
UPDATE – Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering
PONTE VEDRA, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical...
Treace Medical Concepts Announces Pricing of Upsized Initial Public Offering
PONTE VEDRA, Fla., April 22, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopaedic medical...
Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public Offering
SEATTLE, April 22, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (Impel), a late-stage pharmaceutical company focused on utilizing its proprietary...
Golden Leaf’s Innovative Partnership Approach to 420 Leads to Back-to-Back Record Setting Performance
PORTLAND, Ore., April 22, 2021 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (CSE: GLH) (OTCQB: GLDFF) (“Golden Leaf” or the...
Rain Therapeutics Announces Pricing of Initial Public Offering
NEWARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc. (“Rain”), a clinical-stage company developing precision oncology therapeutics, today...
Genocea To Host First Quarter 2021 Corporate Update Conference Call & Webcast
CAMBRIDGE, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies,...
Skylight Health Files Preliminary Base Shelf Prospectus
TORONTO, April 22, 2021 (GLOBE NEWSWIRE) -- Skylight Health Group Inc (TSXV:SHG; OTCQX: SHGFF) (“Skylight Health” or the “Company”), a...
NPR Selects Mom-Owned Business for Distinguished Fellowship
Be Her Village, a revolutionary platform designed by two mothers, beat out thousands of businesses for NPR’s How I Built...
Conformis Announces Achievement of Third Milestone Under Development and License Agreements
BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the...
Adverum Files Investor Presentation Highlighting Significant Strategic Progress and Purpose-Built Board to Oversee Stockholder Value Creation
Urges Stockholders to Vote the WHITE Proxy Card “FOR” ALL of Adverum’s Three Highly Qualified, Diverse and Independent Directors: Dawn...
FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial Cancer
PD-1 Antagonist Antibody Under Clinical Development for Solid Tumors in Collaboration with GlaxoSmithKline (GSK)First AnaptysBio-Generated Antibody, of 8 Currently Under...
Plus Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
Management to host conference call today at 5:00 pm ETAUSTIN, Texas, April 22, 2021 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc....
GENFIT hires Thomas Baetz as Chief Financial Officer and adds two new members to its Executive Committee
Lille, France; Cambridge, MA; April 22, 2021 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...
Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee
Fluidx’s regulatory and clinical affairs director will take the reins of the Regulatory, Compliance and Quality Committee, utilizing his expertise...
Radiko Announces Halt in Cultivation at Carson City and Restructuring of Operations
LOS ANGELES, CA / ACCESSWIRE / April 22, 2021 / Radiko Holdings (CSE:RDKO) (the "Company") announced today that the Company...